ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic RiskByLee Kaplan, MD, PhD,Giuliana GrossiJune 8th 2026New SYNCHRONIZE data signal broad metabolic and hepatic benefits.